Cited by 307Alcohol Consumption and Health EffectsLiver Disease Diagnosis and TreatmentDiet, Metabolism, and Disease

Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease

Open access
Åberg, Fredrik, Byrne, Christopher D., Pirola, Carlos J., Männistö, Ville, Sookoian, Silvia·2023·Journal of Hepatology

Abstract

Alcohol use and metabolic syndrome are highly prevalent in the population and frequently co-exist. Both are implicated in a large range of health problems, including chronic liver disease, hepatocellular carcinoma, and liver-related outcomes (i.e. decompensation or liver transplantation). Studies have yielded mixed results regarding the effects of mild-moderate alcohol consumption on the risk of metabolic syndrome and fatty liver disease, possibly due to methodological differences. The few available prospective studies have indicated that mild-moderate alcohol use is associated with an increase in liver-related outcomes. This conclusion was substantiated by systems biology analyses suggesting that alcohol and metabolic syndrome may play a similar role in fatty liver disease, potentiating an already existing dysregulation of common vital homeostatic pathways. Alcohol and metabolic factors are independently and jointly associated with liver-related outcomes. Indeed, metabolic syndrome increases the risk of liver-related outcomes, regardless of alcohol intake. Moreover, the components of metabolic syndrome appear to have additive effects when it comes to the risk of liver-related outcomes. A number of population studies have implied that measures of central/abdominal obesity, such as the waist-to-hip ratio, can predict liver-related outcomes more accurately than BMI, including in individuals who consume harmful quantities of alcohol. Many studies even point to synergistic interactions between harmful alcohol use and many metabolic components. This accumulating evidence showing independent, combined, and modifying effects of alcohol and metabolic factors on the onset and progression of chronic liver disease highlights the multifactorial background of liver disease in the population. The available evidence suggests that more holistic approaches could be useful for risk prediction, diagnostics and treatment planning.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2022.08.030

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There may be synergy between alcohol consumption and the presence of metabolic risk factors for liver disease progression, with the strongest effect for central obesity.

    “Equally important may be the possible synergy between alcohol consumption and the presence of metabolic risk factors for liver disease progression, 75,83 with the strongest effect for central obesity.”

    From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [75]

    The Abstract reports synergistic interactions between harmful alcohol use and metabolic components for liver-related outcomes. The Introduction identifies waist-to-hip ratio as a key obesity measure in this interaction, and Figure 3 illustrates a marked effect of abdominal obesity. The copy does not establish that central obesity has the strongest interaction of all metabolic risk factors. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 157 · Cited by 307

Authors
Åberg, F., Byrne, C. D., Pirola, C. J., Männistö, V., & Sookoian, S.
Affiliations
  • University of Helsinki (FI)
  • National Health Service (GB)
  • Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
  • University of Eastern Finland (FI)
Corresponding author
  • Åberg, Fredrik
  • Sookoian, Silvia
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2023-01
Volume
78
Issue
1
Pages
191-206
ISSN
0168-8278 (ISSN-L)
OpenAlex
W4294631550
Cited by
307
References
157
Citations by year
2026: 68 · 2025: 106 · 2024: 96 · 2023: 37
FWCI
9.85
Type
journal article
Language
en
Open access
Locations
  • Journal of Hepatology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion)
Funders
  • Academy of Finland (338544)
  • National Institute for Health Research Southampton Biomedical Research Centre (IS-BRC-20004)
  • Agencia Nacional De Promoción Científica Y Tecnológica
  • Fondo para la Investigación Científica y Tecnológica (PICT 2020-00799, PICT 2019-0528, PICT 2018-889, PICT 2018-00620)
  • Consejo Nacional de Investigaciones Científicas y Técnicas (PUE 0055)
  • Finska Läkaresällskapet
  • Finnish Medical Foundation
  • Mary and Georg C Ehrnrooth Foundation
  • Sigrid Jusélius Foundation
  • Kuopion Yliopistollinen Sairaala
  • Medicinska Understodsforeningen Liv och Halsa rf
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
alcohol consumption, metabolic syndrome, chronic liver disease, hepatic steatosis, hepatocellular carcinoma, hepatic decompensation, liver transplantation, abdominal obesity, waist-to-hip ratio, risk prediction, synergistic interaction, systems biology
MeSH terms
Alcohol Drinking, Humans, Liver Neoplasms, Obesity, Prospective Studies, Risk Factors, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review